Catalyst Wire Dossier Catalyst Wire Dossier

intravenous silibinin-legalon

silibinin · Mylan Specialty, LP
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for intravenous silibinin-legalon, covering 2022-04-07 to 2022-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning [Phase 2]

See pricing